MK2 inhibitors and uses thereof
US10253040B1 · kind B1 · utility
11Cited by
11References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2017 |
| Grant date | Apr 9, 2019 |
| Priority date | — |
| Expiry date | Oct 13, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.